HCG
Evidence: A — Established Human EvidenceHormone / Fertility
Evidence Snapshot
What this grade covers
A for identity and FDA-labeled reproductive/endocrine uses (selected male hypogonadotropic hypogonadism, selected prepubertal cryptorchidism, ovulation induction); A for the demonstrated lack of obesity efficacy; D for bodybuilding, TRT-maintenance, anti-aging, or cosmetic-weight-loss claims.
Regulatory Context
FDA-approved hCG products exist for specific reproductive/endocrine indications.
Research Takeaway
Human chorionic gonadotropin (hCG) is a glycoprotein gonadotropin that activates the LH/CG receptor; FDA-approved products include urinary-derived hCG preparations, while recombinant hCG is a separately manufactured form of the same hormonal activity.
Evidence boundary: This identity does not make all urinary, recombinant, compounded, or grey-market hCG products pharmaceutically interchangeable.
See all 6 evidence claims →Quick Summary
Human chorionic gonadotropin (hCG) is a hormone that acts similarly to luteinizing hormone at the LH/hCG receptor. FDA-approved products exist for specific fertility and endocrine uses, while fitness or testosterone-support uses are outside the scope of MitoCore’s medical guidance. On this page, hCG is presented as an established hormone medication for certain indications, with clear warnings about supervision, fertility, estrogenic effects, and misuse.
Mechanism & Research Overview
Human chorionic gonadotropin is a placental glycoprotein hormone composed of alpha and beta subunits, with biologic action similar to luteinizing hormone (LH) and some follicle-stimulating activity. In males, hCG stimulates Leydig cells to produce androgens. In females, it can substitute for the mid-cycle LH surge and trigger final follicular maturation and ovulation after appropriate gonadotropin treatment. hCG is not a short research peptide and must not be presented as a generic wellness compound.
Evidence Claims
Individual scientific statements drawn from the sources cited below, each shown with the specific evidence boundary that statement does not establish.
Supported
Human chorionic gonadotropin (hCG) is a glycoprotein gonadotropin that activates the LH/CG receptor; FDA-approved products include urinary-derived hCG preparations, while recombinant hCG is a separately manufactured form of the same hormonal activity.
Does not establish
Evidence boundary: This identity does not make all urinary, recombinant, compounded, or grey-market hCG products pharmaceutically interchangeable.
Supported
FDA-approved hCG drug products are used in defined reproductive and endocrine indications, so hCG must not be described as an unapproved research peptide as a class.
Does not establish
Evidence boundary: Approval is product- and indication-specific and does not extend to bodybuilding, nonspecific testosterone enhancement, or unapproved grey-market products.
Supported
Human studies support hCG-containing regimens for ovulation triggering and for restoration of gonadal function in selected patients with hypogonadotropic hypogonadism.
Does not establish
Evidence boundary: Combination gonadotropin studies do not establish that hCG alone produces every reported fertility outcome.
Supported
Approved hCG use carries indication-specific safety risks, and reproductive treatment can contribute to adverse events related to ovarian stimulation or gonadotropin exposure.
Does not establish
Evidence boundary: This statement is not a substitute for the current prescribing information and does not quantify individual risk.
Supported
Clinical evidence for approved hCG products does not establish that an unapproved vial labeled 'HCG' has equivalent potency, biological activity, purity, sterility, or stability.
Does not establish
Evidence boundary: This does not assert that every nonapproved product is counterfeit; it states that therapeutic equivalence has not been established.
Supported
Only exact dosing from an FDA-approved label or a named clinical study may appear as Study/Trial Dosing context; consumer fertility, testosterone, cycling, reconstitution, or injection recommendations are outside this evidence package.
Does not establish
Evidence boundary: Study or label dosing must not be converted into individualized treatment guidance.
Safety & Evidence Limitations
Considerations reported in the sources cited on this page — not a complete list of every possible risk, and not medical advice.
Safety Consideration
Can increase testosterone and estradiol signaling, which may worsen acne, mood changes, gynecomastia, water retention, or blood-pressure concerns in some contexts.Safety Consideration
Fertility, testicular function, and endocrine feedback effects require clinician oversight.Safety Consideration
In women, ovarian hyperstimulation and pregnancy-related considerations are important label-level concerns.Safety Consideration
Misuse for fat loss or unsupervised hormone manipulation is unsafe and unsupported.Safety Consideration
Counterfeit or poorly sourced products create potency and identity risks.
Research Areas Being Studied
Research areas discussed on this page reflect the Hormone / Fertility category and the sources cited below.
Findings Reported in Studies
Educational summary only — reported in cited studies, not a claim of proven benefit.
No Human Study Findings Listed Yet
See preclinical, regulatory, and review sources below.
Study Tables by Evidence Type
No Sources Listed Yet
Human, preclinical, regulatory, and review sources will appear here as they are added.
Anecdotal Reported Patterns — Not Medical Advice
Anecdotal Reported Patterns — Not Medical Advice
Reported dosing patterns are included for educational context only. They are self-reported, unverified, not medical advice, and not instructions for human use. Community-submitted patterns are not yet available in this Phase 1 prototype; this section is a placeholder reserved for moderated, aggregated community data.
Lab Markers to Discuss With a Clinician
Educational topics only — not self-monitoring instructions.
FAQ
Disclaimer
hCG is a hormone medication with approved medical uses. MitoCore does not prescribe or recommend hCG, and nothing on this page is fertility, TRT, or weight-loss guidance.
Educational use only. This content is provided for informational and research-summary purposes only. It is not medical advice, not a treatment recommendation, not a dosing guide, and not a substitute for care from a licensed medical professional. Nothing here is intended to diagnose, treat, cure, prevent, or mitigate disease. Reported dosing patterns, when shown elsewhere on the site, must be labeled either as Study / Trial Dosing or Anecdotal Reported Patterns — Not Medical Advice. Community reports are self-reported, unverified, and not scientific proof.
Community-reported experiences, once enabled, must be displayed only as moderated, anonymized, or aggregated data. They are anecdotal, self-reported, unverified, and should never be presented as proof of safety, efficacy, or expected results.
Content status: Website/CMS content draft; source verification and legal/privacy review required before public launch. Last updated 2026-07-26.
Follow research updates for HCG
Get notified in your MitoCore account when this profile is updated, a new study is added, or its evidence grade changes.
Get updates when new studies or safety notes are added for this peptide.
Get educational updates on new studies, evidence-grade changes, and safety notes. Educational content only — not medical advice.